Wooridul Pharmaceutical Mutual Funds

Health Care & Life Sciences » Pharmaceuticals | Wooridul Pharmaceutical Ltd.

Wooridul Pharmaceutical Ltd. | Mutual Funds

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

DFA Emerging Markets Small Cap Series

110,993

0.96%

0.01%

01/31/2018

DFA Emerging Markets Core Equity Portfolio

75,342

0.65%

9,372

04/30/2018

Dimensional Funds ICVC - Emerging Markets Core Equity Fund

3,140

0.03%

12/31/2017

DFA Emerging Markets Social Core Equity Portfolio

2,913

0.03%

04/30/2018

DFA TA World (ex-US) Core Equity Portfolio

2,161

0.02%

04/30/2018

2,056

0.02%

1,122

0.01%

04/30/2018

View Profile

Address	50 Pharmaceutical Ind. Complex 2-gil Hwaseong GY 18622 Korea, Republic Of
Employees	-
Website	http://www.wooridulpharm.com
Updated	07/08/2019
Wooridul Pharmaceutical Ltd. engages in the development and production of medicaments. It operates through the following business divisions: ETC Drug, OTC Drug, Obesity Drug and Health Food. The company was founded on August 22, 1966 and is headquartered in Hwaseong, South Korea.